Literature DB >> 30183452

Platelet microparticles-containing miR-4306 inhibits human monocyte-derived macrophages migration through VEGFA/ERK1/2/NF-κB signaling pathways.

Ying Yang1, Hui Luo2, Si Liu1, Rongyi Zhang1, Xiao Zhu1, Murong Liu1, Houxiang Hu1, Yi Yang1, Zhan Lv1, Mao Chen3.   

Abstract

Platelets are major sources of microparticles (MPs) in peripheral bloodstream, and platelet-secreted MPs (P-MPs) transfer biological information to neighboring cells. In the present study, we found that the platelet- and P-MPs-derived microRNA-4306 (miR-4306) expression were downregulated in coronary artery disease (CAD) and platelet-derived miR-4306 was an independent poor prognostic factor in CAD. Plasma miRNA-4306 mainly cofractionated with MPs instead of Argonaute2 complexes or HDL. P-MPs could effectively deliver miR-4306 into human monocyte-derived macrophages (HMDMs). MiR-4306 noticeably inhibited the HMDMs migration in vitro and reduced the number of macrophage cells in cardiac tissue in myocardial infarction mice. This functional impact of miR-4306 was mediated directly through VEGFA to inhibit ERK/NF-κB signaling. In conclusion, our study suggested that intercellular transfer of miR-4306 by platelet microparticles inhibited the HMDMs migration through VEGFA/ERK1/2/NF-κB signaling pathways.

Entities:  

Keywords:  Platelet; coronary artery disease; miR-4306; microparticles; vascular endothelial growth factor A

Mesh:

Substances:

Year:  2018        PMID: 30183452     DOI: 10.1080/10641963.2018.1510941

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  7 in total

1.  Identification of Key Endometrial MicroRNAs and Their Target Genes Associated With Pathogenesis of Recurrent Implantation Failure by Integrated Bioinformatics Analysis.

Authors:  Jin Shang; Yan-Fei Cheng; Min Li; Hui Wang; Jin-Ning Zhang; Xin-Meng Guo; Dan-Dan Cao; Yuan-Qing Yao
Journal:  Front Genet       Date:  2022-06-22       Impact factor: 4.772

2.  The ceRNA Crosstalk between mRNAs and lncRNAs in Diabetes Myocardial Infarction.

Authors:  Yun Zhou; Chengjun Zhou; Lilong Wei; Chengwu Han; Yongtong Cao
Journal:  Dis Markers       Date:  2022-05-09       Impact factor: 3.464

Review 3.  Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target.

Authors:  Qianru Leng; Jie Ding; Meiyan Dai; Lei Liu; Qing Fang; Dao Wen Wang; Lujin Wu; Yan Wang
Journal:  Front Cardiovasc Med       Date:  2022-06-09

Review 4.  Exploring the role of non-coding RNAs in autophagy.

Authors:  Soudeh Ghafouri-Fard; Hamed Shoorei; Mahdi Mohaqiq; Jamal Majidpoor; Mohammad Amin Moosavi; Mohammad Taheri
Journal:  Autophagy       Date:  2021-02-18       Impact factor: 13.391

5.  Identification of Genetic Biomarkers for Diagnosis of Myocardial Infarction Compared with Angina Patients.

Authors:  Yuanyuan Zhang; Chunyang Tian; Xuejian Liu; He Zhang
Journal:  Cardiovasc Ther       Date:  2020-11-10       Impact factor: 3.023

Review 6.  Role of MicroRNAs in the Pathogenesis of Coronary Artery Disease.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Cardiovasc Med       Date:  2021-04-12

Review 7.  Nrf2-Related Therapeutic Effects of Curcumin in Different Disorders.

Authors:  Soudeh Ghafouri-Fard; Hamed Shoorei; Zahra Bahroudi; Bashdar Mahmud Hussen; Seyedeh Fahimeh Talebi; Mohammad Taheri; Seyed Abdulmajid Ayatollahi
Journal:  Biomolecules       Date:  2022-01-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.